| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |